Calcium in PDB 3lka: Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide
Enzymatic activity of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide
All present enzymatic activity of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide:
3.4.24.65;
Protein crystallography data
The structure of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide, PDB code: 3lka
was solved by
V.Calderone,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
36.91 /
1.80
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
51.566,
60.194,
54.215,
90.00,
115.09,
90.00
|
R / Rfree (%)
|
16.9 /
21
|
Other elements in 3lka:
The structure of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide
(pdb code 3lka). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 3 binding sites of Calcium where determined in the
Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide, PDB code: 3lka:
Jump to Calcium binding site number:
1;
2;
3;
Calcium binding site 1 out
of 3 in 3lka
Go back to
Calcium Binding Sites List in 3lka
Calcium binding site 1 out
of 3 in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca266
b:17.5
occ:1.00
|
O
|
A:GLY190
|
2.2
|
11.3
|
1.0
|
O
|
A:HOH289
|
2.3
|
15.7
|
1.0
|
O
|
A:GLY192
|
2.5
|
6.7
|
1.0
|
O
|
A:ASP158
|
2.6
|
8.3
|
1.0
|
OD2
|
A:ASP194
|
2.6
|
7.0
|
1.0
|
O
|
A:HOH7
|
2.7
|
8.5
|
1.0
|
C
|
A:GLY190
|
3.4
|
12.3
|
1.0
|
CG
|
A:ASP194
|
3.5
|
7.2
|
1.0
|
C
|
A:ASP158
|
3.6
|
8.0
|
1.0
|
C
|
A:GLY192
|
3.6
|
7.2
|
1.0
|
OD1
|
A:ASP194
|
3.7
|
11.2
|
1.0
|
C
|
A:ILE191
|
3.8
|
10.8
|
1.0
|
O
|
A:ALA157
|
3.9
|
11.4
|
1.0
|
O
|
A:ILE191
|
4.0
|
11.0
|
1.0
|
N
|
A:GLY192
|
4.1
|
10.0
|
1.0
|
O
|
A:HOH32
|
4.1
|
10.5
|
1.0
|
CA
|
A:ILE191
|
4.1
|
11.7
|
1.0
|
N
|
A:ILE191
|
4.2
|
11.3
|
1.0
|
N
|
A:ASP194
|
4.4
|
5.8
|
1.0
|
CA
|
A:ASP158
|
4.4
|
9.0
|
1.0
|
CA
|
A:GLY192
|
4.4
|
8.5
|
1.0
|
N
|
A:ILE159
|
4.5
|
7.5
|
1.0
|
CA
|
A:GLY190
|
4.5
|
12.5
|
1.0
|
CA
|
A:ILE159
|
4.6
|
7.0
|
1.0
|
O
|
A:GLY188
|
4.6
|
12.4
|
1.0
|
N
|
A:LEU160
|
4.6
|
6.0
|
1.0
|
N
|
A:GLY190
|
4.6
|
11.7
|
1.0
|
N
|
A:GLY193
|
4.6
|
7.3
|
1.0
|
CB
|
A:ASP194
|
4.7
|
6.5
|
1.0
|
O
|
A:HOH27
|
4.7
|
10.5
|
1.0
|
CA
|
A:GLY193
|
4.7
|
6.5
|
1.0
|
C
|
A:GLY193
|
4.8
|
6.5
|
1.0
|
C
|
A:ALA157
|
4.9
|
11.6
|
1.0
|
CA
|
A:ASP194
|
4.9
|
7.1
|
1.0
|
C
|
A:SER189
|
4.9
|
12.1
|
1.0
|
|
Calcium binding site 2 out
of 3 in 3lka
Go back to
Calcium Binding Sites List in 3lka
Calcium binding site 2 out
of 3 in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca267
b:8.1
occ:1.00
|
OD2
|
A:ASP124
|
2.3
|
4.6
|
1.0
|
O
|
A:GLU199
|
2.3
|
5.1
|
1.0
|
OE2
|
A:GLU199
|
2.4
|
5.2
|
1.0
|
O
|
A:HOH16
|
2.5
|
5.6
|
1.0
|
O
|
A:HOH21
|
2.6
|
6.5
|
1.0
|
O
|
A:GLU201
|
2.6
|
5.5
|
1.0
|
OD1
|
A:ASP124
|
2.6
|
2.0
|
1.0
|
CG
|
A:ASP124
|
2.8
|
5.2
|
1.0
|
CD
|
A:GLU199
|
3.4
|
6.4
|
1.0
|
C
|
A:GLU199
|
3.5
|
6.3
|
1.0
|
C
|
A:GLU201
|
3.8
|
5.6
|
1.0
|
CG
|
A:GLU199
|
3.8
|
4.7
|
1.0
|
OG1
|
A:THR122
|
4.0
|
4.8
|
1.0
|
CA
|
A:GLU199
|
4.1
|
5.4
|
1.0
|
O
|
A:HOH40
|
4.3
|
15.0
|
1.0
|
CB
|
A:ASP124
|
4.3
|
5.5
|
1.0
|
CA
|
A:PHE202
|
4.3
|
5.2
|
1.0
|
CD1
|
A:TRP203
|
4.4
|
3.2
|
1.0
|
N
|
A:PHE202
|
4.5
|
5.0
|
1.0
|
OE1
|
A:GLU199
|
4.6
|
7.4
|
1.0
|
N
|
A:ASP200
|
4.6
|
7.2
|
1.0
|
CB
|
A:GLU199
|
4.6
|
5.0
|
1.0
|
N
|
A:GLU201
|
4.6
|
7.0
|
1.0
|
C
|
A:ASP200
|
4.7
|
7.7
|
1.0
|
N
|
A:TRP203
|
4.8
|
4.9
|
1.0
|
CA
|
A:ASP200
|
4.8
|
7.6
|
1.0
|
NH2
|
A:ARG165
|
4.8
|
13.2
|
1.0
|
CA
|
A:GLU201
|
4.8
|
6.3
|
1.0
|
O
|
A:HOH29
|
4.8
|
8.6
|
1.0
|
CD1
|
A:PHE202
|
4.8
|
5.9
|
1.0
|
NE1
|
A:TRP203
|
4.9
|
2.0
|
1.0
|
|
Calcium binding site 3 out
of 3 in 3lka
Go back to
Calcium Binding Sites List in 3lka
Calcium binding site 3 out
of 3 in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca268
b:10.3
occ:1.00
|
OE2
|
A:GLU201
|
2.3
|
14.0
|
1.0
|
OD1
|
A:ASP198
|
2.3
|
4.3
|
1.0
|
O
|
A:GLY176
|
2.3
|
10.9
|
1.0
|
O
|
A:ILE180
|
2.3
|
8.8
|
1.0
|
O
|
A:GLY178
|
2.4
|
11.9
|
1.0
|
OD2
|
A:ASP175
|
2.4
|
12.1
|
1.0
|
CG
|
A:ASP198
|
3.3
|
4.5
|
1.0
|
C
|
A:ILE180
|
3.5
|
8.4
|
1.0
|
CD
|
A:GLU201
|
3.5
|
10.3
|
1.0
|
C
|
A:GLY176
|
3.5
|
10.1
|
1.0
|
C
|
A:GLY178
|
3.6
|
10.2
|
1.0
|
CG
|
A:ASP175
|
3.6
|
13.2
|
1.0
|
N
|
A:GLY178
|
3.9
|
10.3
|
1.0
|
CB
|
A:ASP198
|
4.0
|
4.0
|
1.0
|
N
|
A:ILE180
|
4.0
|
8.8
|
1.0
|
OE1
|
A:GLU201
|
4.1
|
8.1
|
1.0
|
OD1
|
A:ASP175
|
4.2
|
12.3
|
1.0
|
C
|
A:LYS177
|
4.2
|
10.9
|
1.0
|
N
|
A:GLY176
|
4.2
|
9.0
|
1.0
|
OD2
|
A:ASP198
|
4.3
|
4.1
|
1.0
|
CA
|
A:ILE180
|
4.3
|
8.9
|
1.0
|
N
|
A:ASP175
|
4.3
|
9.8
|
1.0
|
CA
|
A:GLY178
|
4.3
|
11.2
|
1.0
|
C
|
A:GLY179
|
4.3
|
9.9
|
1.0
|
C
|
A:ASP175
|
4.3
|
9.4
|
1.0
|
N
|
A:LEU181
|
4.4
|
7.8
|
1.0
|
N
|
A:LYS177
|
4.4
|
10.0
|
1.0
|
CA
|
A:LYS177
|
4.4
|
10.8
|
1.0
|
CA
|
A:GLY176
|
4.4
|
9.4
|
1.0
|
CA
|
A:LEU181
|
4.5
|
7.3
|
1.0
|
CG
|
A:GLU201
|
4.5
|
7.7
|
1.0
|
N
|
A:GLY179
|
4.6
|
11.1
|
1.0
|
O
|
A:ASP175
|
4.6
|
9.3
|
1.0
|
CA
|
A:ASP175
|
4.7
|
10.2
|
1.0
|
CA
|
A:GLY179
|
4.7
|
9.7
|
1.0
|
CB
|
A:ILE180
|
4.7
|
9.3
|
1.0
|
CB
|
A:ASP175
|
4.7
|
10.2
|
1.0
|
O
|
A:LYS177
|
4.8
|
10.6
|
1.0
|
O
|
A:GLY179
|
4.8
|
9.8
|
1.0
|
|
Reference:
V.Borsi,
V.Calderone,
M.Fragai,
C.Luchinat,
N.Sarti.
Entropic Contribution to the Linking Coefficient in Fragment Based Drug Design: A Case Study. J.Med.Chem. V. 53 4285 2010.
ISSN: ISSN 0022-2623
PubMed: 20415416
DOI: 10.1021/JM901723Z
Page generated: Sat Jul 13 13:08:57 2024
|